XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Tables)
12 Months Ended
Sep. 30, 2023
Income Taxes [Abstract]  
Schedule of Income Tax Expense (Benefit) Differs from the Amount of Income Tax The income tax expense (benefit) differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income for the years ended September 30, 2023 and 2022 due to the following:
   2023   2022 
Computed “expected” tax benefit   (21.0)%   (21.0)%
Increase (decrease) in income taxes resulting from:          
State taxes, net of federal benefit   (6.3)   (6.3)
Permanent differences   3.7    1.8 
Increase in the valuation reserve   25.4    27.2 
    1.8%   1.7%
Schedule of Deferred Income Taxes Reflect the Net Tax Effects of Temporary Differences Significant components of the Company’s deferred tax assets and liabilities are as follows:
   September 30,
2023
   September 30,
2022
 
Deferred tax assets:        
Net operating loss carryforward  $34,980,000   $34,673,000 
Stock-based compensation   2,191,000    1,569,000 
Capitalized research and development   3,644,000      
Other   4,100,000    3,689,000 
Valuation allowance on deferred tax assets   (44,915,000)   (39,931,000)
Total deferred tax assets        
Deferred tax liabilities:          
In-process research and development   (6,137,800)   (5,561,800)
Total deferred tax liability   (6,137,800)   (5,561,800)
Net deferred tax liability  $(6,137,800)  $(5,561,800)